Black Diamond Therapeutics, Inc. - BDTX

SEC FilingsOur BDTX Tweets

About Gravity Analytica

Recent News

  • 06.04.2025 - Jefferies Global Healthcare Conference 2025
  • 06.04.2025 - Jefferies Global Healthcare Conference 2025
  • 05.29.2025 - Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
  • 05.29.2025 - Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
  • 05.12.2025 - Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
  • 05.12.2025 - Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
  • 04.08.2025 - Stifel 2025 Virtual Targeted Oncology Forum
  • 04.08.2025 - Stifel 2025 Virtual Targeted Oncology Forum
  • 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference
  • 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference

Recent Filings

  • 05.12.2025 - 8-K Current report
  • 05.12.2025 - EX-99.1 EX-99.1
  • 05.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 04.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 04.18.2025 - ARS Annual Report to Security Holders
  • 04.18.2025 - DEF 14A Other definitive proxy statements
  • 04.18.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 03.21.2025 - 4 Statement of changes in beneficial ownership of securities